research
Borrelia Proteins Studied in Latvia to Improve a Lyme Disease Vaccine
In the coming years, a vaccine against tick-borne Lyme disease developed by Pfizer may enter the pharmaceutical market. Meanwhile, research continues at the Latvian Biomedical Research and Study Centre that could lead to even more effective vaccines against this disease.
Lyme disease, caused…
Ilze Kuzmina, Latvian News Service
February 16, 2026